1. Academic Validation
  2. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis

Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis

  • Nature. 1990 Jan 18;343(6255):282-4. doi: 10.1038/343282a0.
R A Dixon 1 R E Diehl E Opas E Rands P J Vickers J F Evans J W Gillard D K Miller
Affiliations

Affiliation

  • 1 Department of Molecular Biology, Merck Sharp & Dohme Research Laboratories, West Point, Pennsylvania 19486.
Abstract

Leukotrienes, the biologically active metabolites of arachidonic acid, have been implicated in a variety of inflammatory responses, including asthma, arthritis and psoriasis. Recently a compound, MK-886, has been described that blocks the synthesis of leukotrienes in intact activated leukocytes, but has little or no effect on Enzymes involved in leukotriene synthesis, including 5-lipoxygenase, in cell-free systems. A membrane protein with a high affinity for MK-886 and possibly representing the cellular target for MK-886 has been isolated from rat and human leukocytes. Here, we report the isolation of a complementary DNA clone encoding the MK-886-binding protein. We also demonstrate that the expression of both the MK-886-binding protein and 5-lipoxygenase is necessary for leukotriene synthesis in intact cells. Because the MK-886-binding protein seems to play a part in activating this Enzyme in cells, it is termed the five-lipoxygenase activating protein (FLAP).

Figures